Key result
In patients with one-vessel LAD coronary disease, complications differed significantly between stent types, with 75% of restenosis cases occurring in those treated with bare metal stents.
Why the study?
The study aimed to estimate one-year survival and left heart systolic function after PCI treatment in patients with one-vessel LAD coronary artery disease to guide better treatment strategies.
Does PCI with DES compared to BMS improve survival and left heart systolic function in patients with one-vessel LAD disease?
Cohort (n=60)
Does PCI with DES compared to BMS improve survival and left heart systolic function in patients with one-vessel LAD disease?
In patients with one-vessel LAD disease, the use of drug-eluting stents is justified over bare-metal stents due to a higher rate of restenosis complications associated with the latter.
INTRODUCTION: The dominant global public health challenge are non-communicable diseases. According to World Health Organization (WHO) data. The fifth leading causes of death in FB&H are diseases of the heart and coronary arteries: stroke, acute myocardial infarction, cardiac arrest, cardiomyopathy and essential hypertension. The prevention of these diseases has great importance in improving health in B&H. OBJECTIVE: The aim of this study is in estimation of one-year survival and left heart systolic function after the treatment. After the data collection and evidence of their statistical value, the results of the research point to the profile of patients with a LAD disease in one-vessel coronary artery disease that should be subjected to PCI DES LAD and PCI BMS LAD, respectively, or creating guidelines for a better and more effective LAD treatment. MATERIAL AND METHODS: The study was performed as retrospective/ prospective, clinically controlled for a period of three years. In this study was included 60 patients, which was followed in 12 months period. With the PCI BMS method was treated 63.3% and 36.7% of subjects were treated with the PCI DES in LAD. CONCLUSION: The number of complications in patients with one-vessel LAD coronary heart disease, treated with PCI DES and PCI BMS was statistically significant. One possible complication (4 patients) is due to the spread of the disease to other blood vessels. Due to possible complications in the treated or LAD with repeated stenosis, the complication in terms of restenosis of the previously placed stent in 75% are with BM stents justifying the use of drug eluting stent, while the progression of disease in patients (2 patients) indicates the need for detection and prevention of risk factors.
No takes yet. Share an insight, caveat, or question.
Cibo et al. (2018) conducted a cohort in One-vessel LAD coronary artery disease (n=60). Percutaneous Coronary Intervention with Drug Eluting Stent (PCI DES) vs. Percutaneous Coronary Intervention with Bare Metal Stent (PCI BMS) was evaluated on Complications including restenosis. In patients with one-vessel LAD coronary disease, complications differed significantly between stent types, with 75% of restenosis cases occurring in those treated with bare metal stents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: